Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Gsk Plc (GSK.L)

GSK Announces Approval For Exdensur In China 3/30/2026 2:13:09 AM

GSK: China's NMPA Approves Exdensur For The Treatment Of Severe Asthma 3/30/2026 2:02:20 AM

GSK: European Medicines Agency To Review MAA For Bepirovirsen 3/27/2026 3:56:31 AM

GSK: EMA Accepts For Review MAA For Use Of Bepirovirsen For Adults With Chronic Hepatitis B 3/27/2026 3:10:06 AM

Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults 3/24/2026 9:14:37 PM

GSK Secures Japan Orphan Drug Designation For Risvutatug Rezetecan In Small-cell Lung Cancer 3/23/2026 3:18:00 AM

GSK Gets Orphan Drug Designation For Risvutatug Rezetecan In Small-Cell Lung Cancer In Japan 3/23/2026 3:02:11 AM

Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LNSR Ends Merger Deal 3/20/2026 10:13:56 AM

GSK's Lynavoy Wins FDA Approval For Cholestatic Pruritus Treatment In US 3/19/2026 9:29:05 AM

FDA Approves GSK's Lynavoy For Cholestatic Pruritus In Primary Biliary Cholangitis 3/19/2026 8:43:25 AM

GSK Says FDA Expands Arexvy RSV Vaccine Approved Age To Adults 18 To 49 Years At Increased Risk 3/13/2026 10:35:00 AM

FDA Expands GSK's Arexvy RSV Vaccine Approval To Adults 18-49 At Increased Risk 3/13/2026 10:05:21 AM

GSK: Alfasigma To Acquire Rights To Develop, Manufacture, Commercialise Linerixibat 3/9/2026 3:33:24 AM

GSK: Alfasigma To Buy Worldwide Rights To Develop Linerixibat For Cholestatic Pruritus In PBC 3/9/2026 3:07:01 AM

GSK's NDA For Bepirovirsen Accepted In Japan For Chronic Hepatitis B 2/26/2026 3:36:14 AM

GSK's Bepirovirsen Accepted For Regulatory Review In Japan For Chronic Hepatitis B 2/26/2026 2:21:28 AM

Biotech Stocks Facing FDA Decision In March 2026 2/25/2026 3:06:28 AM

GSK To Acquire 35Pharma For $950 Mln 2/25/2026 2:48:23 AM

GSK Agrees To Acquire 35Pharma Inc 2/25/2026 2:06:07 AM

Bora Pharmaceuticals Signs $250 Mln Five-Year Manufacturing Deal With GSK; Bora Stock Up 2/24/2026 1:05:40 AM

- « Previous
- 1
- 2
- 3
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap